Red Blood Cell Transfusion Safety: Probabilistic Risk Assessment and Cost/ Benefits of Risk Reduction Strategies
- 327 Downloads
While transfusion safety, particularly with respect to transfusion-transmitted infectious diseases, has improved dramatically over the past several decades, progress in other clinical processes of blood product transfusion continue with highly variable practices and human errors that contribute to adverse outcomes. In this paper, we study the adverse outcome risk in red blood cell (RBC) transfusion in the United States using Probabilistic Risk Assessment (PRA). PRA allows us to map, in a comprehensive manner, the various types of events that may contribute to an adverse outcome, including socio-technical factors such as the risk coming from human error; and allows us to formalize the logical relationships among those events and the adverse outcome risk. We utilize the PRA model to assess the risk to the patient from RBC transfusion in the United States, to identify the major risk points in the transfusion process, and to evaluate the costs and benefits of several risk reduction strategies. Our data come from published studies in the medical literature.
We find that the risk of a potentially severe outcome (e.g., mortality, major injury or other serious long-term consequences, a life threatening incident) from RBC transfusion lies in the interval [10.4327,511.2] per 100,000 units of RBC transfused, with a point estimate of 25.4527. The leading causes of severe outcomes include circulatory overload and bacterial infection. Acute hemolytic reactions, which are mainly caused by erroneous administration of the blood, also contribute significantly to severe outcomes of transfusion. Interestingly, our analysis indicates that an intervention that is targeted at reducing the risk of the erroneous administration of blood (through training programs or technology investments) has a higher potential impact in reducing the severe outcome risk from RBC transfusion than additional screening to further reduce the risk of transfusion-transmitted viral infections, of HIV 1-2, hepatitis B, and hepatitis C, which the lay public fears most. Furthermore, such an error reduction program will be more cost-effective than the additional screening of donated blood. Our study provides guidelines for public policy to improve the safety of RBC transfusion in the United States.
KeywordsTransfusion Patient safety Risk Probabilistic risk assessment
Unable to display preview. Download preview PDF.
- Bierbaum, B. E., Callaghan, J. J., & Galante, J. O. (1999). An analysis of blood management in patients having a total hip or knee arthroplasty. Journal of Bone and Joint Surgery. American Volume, 81A, 2–10. Google Scholar
- Burgmeier, J. (2002). Failure mode and effect analysis: An application in reducing risk in blood transfusion. Journal of Quality Improvement, 28, 331–339. Google Scholar
- Chen, B., Avrunin, G. S., Clarke, L. A., & Osterweil, L. J. (2006). Automatic fault tree derivation from little-JIL process definitions. In Q. Wang, D. Pfahl, D. Raffo, & P. Wernick (Eds.), Lecture notes in computer science: Vol. 3966. Software process change (pp. 150–158). Berlin: Springer. CrossRefGoogle Scholar
- Dodd, R. Y. (1994). Adverse Consequences of blood transfusion: Quantitative risk estimates. In S. T. Nance (Ed.), Blood supply: Risks perceptions, and prospects for the future (pp. 1–24). Bethesda: American Association of Blood Banks. Google Scholar
- Dzik, W. H. (2005). Technology for enhanced transfusion safety. American Society of Hematology (pp. 476–482). Google Scholar
- Dzik, W. H., & Cooley, E. (2003). Lecture 2002: Transfusion safety in the hospital. Transfusion, 1190–1198. Google Scholar
- Goodnough, L. T. (2003). Risk of blood transfusion. Critical Care Medicine, 31(12 (Suppl.)), 680–686. Google Scholar
- Haimes, Y. Y. (1998). Risk modeling, assessment, and management. New York: Wiley. Google Scholar
- Leiby, D. A. (2001). Parasites and other emergent infectious agents. In S. Stramer (Ed.), Blood safety in the new millenium (pp. 55–78). Bethesda: American Association of Blood Banks. Google Scholar
- Lyons, M., Adams, S., Woloshynowych, M., & Vincent, C. (2004). Human reliability analysis in healthcare: A review of techniques. The International Journal of Risk and Safety in Medicine 16, 223–237. Google Scholar
- Mayer, K. (1982). A Different view of transfusion safety—Type and screen, transfusion of Coombs incompatible cells, and fatal transfusion induced graft versus host disease. In H. F. Polesky & R. H. Walker (Eds.), Safety in transfusion practices. Skokie: College of American Pathologists. Google Scholar
- Mazzei, C. A., Popovsky, M. A., & Kopko, P. M. (2002). Noninfectious complications of blood transfusion. In M. E. Brecher (Ed.), AABB technical manual (14th ed.) (pp. 586–587). Bethesda: American Association of Blood Banks. Google Scholar
- Popovsky, M. A., & Taswell, H. F. (1985). Circulatory overload: An underdiagnosed consequence of transfusion. Transfusion, 25, 469. Google Scholar
- Rausand, M., & Høyland, A. (2004). Wiley series in probability and statistics. System reliability theory: Models, statistical methods, and applications (2nd ed.). Hoboken: Wiley-Interscience. Google Scholar
- Ross, S. M. (2007). Introduction to probability models. Amsterdam: Academic Press. Google Scholar
- Schaefer, A. J., Bailey, M. D., Shechter, S. M., & Roberts, M. S. (2004). Modeling medical treatment using Markov decision processes. In M. L. Brandeau, F. Sainfort, & W. P. Pierskalla (Eds.), Kluwer’s International Series Operations research and health care (pp. 593–612). Berlin: Springer. Google Scholar
- Stramer, S. L. (2007). Current risks of transfusion-transmitted agents: A review. Archives of Pathology & Laboratory Medicine, 131, 702–707. Google Scholar
- Stramer, S. L., Dodd, R. Y., & Leiby, D. A. (2007). Blood donor screening for Chagas disease—United States, 2006–2007. Morbidity and Mortality Weekly Report, 56, 141–143. Google Scholar